156 related articles for article (PubMed ID: 25000506)
81. Isoflavanquinones from Abrus precatorius roots with their antiproliferative and anti-inflammatory effects.
Okoro EE; Maharjan R; Jabeen A; Ahmad MS; Azhar M; Shehla N; Zaman W; Shams S; Osoniyi OR; Onajobi FD; Choudhary MI
Phytochemistry; 2021 Jul; 187():112743. PubMed ID: 33962136
[TBL] [Abstract][Full Text] [Related]
82. PERORAL ADMINISTRATION OF AURANTIN IN TREATMENT OF EHRLICH'S CARCINOMA.
GRACHEVA NP; AKOPYANTS SS; KHARITONOVA AM
Fed Proc Transl Suppl; 1964; 23():43-5. PubMed ID: 14112004
[No Abstract] [Full Text] [Related]
83. Niosomal plumbagin with reduced toxicity and improved anticancer activity in BALB/C mice.
Naresh RA; Udupa N; Devi PU
J Pharm Pharmacol; 1996 Nov; 48(11):1128-32. PubMed ID: 8961159
[TBL] [Abstract][Full Text] [Related]
84. [MORTALITY, VIRAL GROWTH AND INTERFERON PRODUCTION IN EXPERIMENTAL VIRAL INFECTION OF MICE BEARING EHRLICH'S ASCITES CANCER].
BENDINELLI M; RUSCHI A; SANTOPADRE G
Riv Ital Ig; 1963; 23():418-29. PubMed ID: 14123077
[No Abstract] [Full Text] [Related]
85. Variable response of spleen to ehrlich's tumor according to the physical form (ascitic or solid) of the tumor.
Rivenson A; Schnelle V; Moroson H; Madden R; Herp A
Experientia; 1981 Feb; 37(2):195-7. PubMed ID: 7238756
[No Abstract] [Full Text] [Related]
86. STUDIES ON MALIGNOLIPIN. XI. EFFECT OF MALIGNOLIPIN ON THE SURVIVAL PERIOD OF MICE BEARING EHRLICH'S ASCITES CANCER. PRELIMINARY REPORT.
KOSAKI T; MURAKI K; NAGAYASU N; NAKAGAWA S
Mie Med J; 1963; 13():43-9. PubMed ID: 14218692
[No Abstract] [Full Text] [Related]
87. The detection of curcumins' antitumoral effects via argyrophilic nucleolar organizing region-associated protein synthesis in mice with ehrlich's ascitic carcinoma.
Nisari M; Yilmaz S; Eroz R; Ertekin T; Bircan D; Ulger H
Bratisl Lek Listy; 2017; 118(1):61-65. PubMed ID: 28127985
[TBL] [Abstract][Full Text] [Related]
88. Immunization against Ehrlich's ascites carcinoma with streptomycin complexes from tumour cells.
POLGLASE WJ
Nature; 1963 Jan; 197():301-2. PubMed ID: 13944309
[No Abstract] [Full Text] [Related]
89. Modulation of tumour cell colony growth in soft agar by oxygen and its mechanism.
Gupta V; Eberle R
Br J Cancer; 1984 May; 49(5):587-93. PubMed ID: 6326792
[TBL] [Abstract][Full Text] [Related]
90. [Effect of six different strains of mycobacterium bovis--BCG upon the growth of subcutaneously transplanted Ehrlich's tumor in mice (author's transl)].
Schwartz E; Vincúrová M; Dornetzhuber V
Bratisl Lek Listy; 1980 Sep; 74(3):321-30. PubMed ID: 7417869
[No Abstract] [Full Text] [Related]
91. Oral polyethylene glycol's inhibitory effect on the subcutaneous growth of Ehrlich's carcinoma in mice, and on the local inflammatory response to the tumour.
Hartveit F
Acta Pathol Microbiol Scand; 1969; 77(4):623-38. PubMed ID: 5383840
[No Abstract] [Full Text] [Related]
92. On the uptake of bacteriophages by Ehrlich's ascites cancer cell. Part I.
Akiyama S; Tsubouchi J; Kurosawa K
Keio J Med; 1976 Apr; 25(2):55-65. PubMed ID: 1003717
[No Abstract] [Full Text] [Related]
93. Cytotoxic and Antitumour Studies of Acetoacetanilide N(4)-methyl(phenyl)thiosemicarbazone and its Transition Metal Complexes.
Priya NP; Firdous AP; Jeevana R; Aravindakshan KK
Indian J Pharm Sci; 2015; 77(6):655-60. PubMed ID: 26997691
[TBL] [Abstract][Full Text] [Related]
94. Novel biogenic silver nanoconjugates of Abrus precatorius seed extracts and their antiproliferative and antiangiogenic efficacies.
Kaur A; Sharma Y; Singh G; Kumar A; Kaushik N; Khan AA; Bala K
Sci Rep; 2023 Aug; 13(1):13514. PubMed ID: 37598190
[TBL] [Abstract][Full Text] [Related]
95. The survival time of mice with Ehrlich's ascites carcinoma related to the sex and weight of the mouse. and the blood content of the tumour.
HARTVEIT F
Br J Cancer; 1961 Jun; 15(2):336-41. PubMed ID: 13712026
[No Abstract] [Full Text] [Related]
96. Evaluation of Anticancer Activity of
Vladić J; Ćebović T; Vidović S; Jokić S
Plants (Basel); 2020 Nov; 9(11):. PubMed ID: 33182763
[No Abstract] [Full Text] [Related]
97. Chemopreventive and anti-breast cancer activity of compounds isolated from leaves of
Sofi MS; Sateesh MK; Bashir M; Ganie MA; Nabi S
3 Biotech; 2018 Aug; 8(8):371. PubMed ID: 30105196
[TBL] [Abstract][Full Text] [Related]
98. Effect of
Hasan MM; Islam MS; Hoque KMF; Haque A; Reza MA
Toxicol Res; 2019 Jul; 35(3):271-277. PubMed ID: 31341556
[No Abstract] [Full Text] [Related]
99. Peptides as Potential Anticancer Agents.
Aaghaz S; Gohel V; Kamal A
Curr Top Med Chem; 2019; 19(17):1491-1511. PubMed ID: 30686254
[TBL] [Abstract][Full Text] [Related]
100. Study on the potential hypoglycemic flavonoids in
Yuan X; Xue X; Liang Z; He C
Nat Prod Res; 2024 Apr; ():1-8. PubMed ID: 38623836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
